TREA

79294807 - NUCLERA

Follow

Information

  • Trademark
  • 79294807
  • Serial Number
    79294807
  • Registration Number
    6624194
  • Filing Date
    November 19, 2019
    5 years ago
  • Registration Date
    January 25, 2022
    3 years ago
  • Transaction Date
    June 16, 2023
    a year ago
  • Status Date
    January 25, 2022
    3 years ago
  • Published for Opposition Date
    June 08, 2021
    3 years ago
  • Location Date
    January 25, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CHHINA, KARANENDRA S
  • Attorney Docket Number
    60895-540173
    Attorney Name
    Rebecca Liebowitz
    Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NUCLERA
Case File Statements
  • GS0401: Custom manufacture of therapeutic drugs, including therapeutic DNA, RNA, genes and oligonucleotides; manufacture of synthetic DNA, RNA, genes and oligonucleotides for others
  • GS0091: Scientific research and laboratory apparatus, namely, scientific desktop instruments for gene, RNA and protein synthesis; semiconductors, semiconductor chips, microchips, bio-sensors, bio-chips; scientific research and laboratory apparatus, namely, apparatus for amplifying DNA and RNA, apparatus for manufacturing DNA and RNA, apparatus for processing DNA and RNA; apparatus for recording, transmission or reproduction of data including video, audio, images and text for scientific purposes; data processing equipment and computers; computer hardware; downloadable and recorded computer software for scientific data analysis; downloadable and recorded computer programs for scientific data analysis; data carriers containing scientific data; parts and fittings for all the aforesaid goods
  • GS0051: Biological, chemical and biochemical reagents, namely, DNA and RNA products, proteins and gene editing enzymes for clinical or medical laboratory use; pharmaceutical and veterinary preparations, namely, nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; therapeutic DNA and RNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes
  • GS0011: Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, DNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological and biochemical reagents; gene editing enzymes
  • GS0441: Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testing, sequencing and measuring services for medical and health purposes; provision of information relating to the analysis of DNA and RNA for medical and health purposes; providing advice and consultancy in the field of medical and veterinary therapies
  • GS0101: Medical and veterinary apparatus and instruments namely, apparatus for DNA and RNA analysis, sequencing and synthesis; apparatus for gene, RNA and protein synthesis for medical and veterinary purposes
  • GS0421: Scientific and technological services, namely , scientific research, structural and functional analysis of genomes and genetic testing and in the fields of genomics, DNA and RNA sequencing, gene synthesis, RNA synthesis, protein synthesis, gene identification, gene cloning, gene expression, gene mapping, and research and design in the field of DNA research and development, gene and protein synthesis; chemical and biological analysis and research services; research into DNA and RNA for scientific purposes; research and development into the creation of DNA and RNA; research, development, scientific testing and analysis in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene-editing services for scientific research purposes; DNA and RNA modelling services for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating libraries or collections of normal and mutated genes for scientific research purposes; electronic data storage services; consultancy and advisory services relating to the aforesaid services
Case File Event Statements
  • 6/15/2023 - a year ago
    31 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 7/25/2022 - 2 years ago
    30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 6/30/2022 - 2 years ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/29/2022 - 2 years ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 4/25/2022 - 2 years ago
    27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 1/25/2022 - 3 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/17/2021 - 3 years ago
    25 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB
  • 12/16/2021 - 3 years ago
    24 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 12/16/2021 - 3 years ago
    23 - ASSIGNED TO PETITION STAFF Type: APET
  • 12/1/2021 - 3 years ago
    22 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 6/29/2021 - 3 years ago
    21 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 6/8/2021 - 3 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/8/2021 - 3 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/19/2021 - 3 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/4/2021 - 3 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/4/2021 - 3 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/4/2021 - 3 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/4/2021 - 3 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/4/2021 - 3 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/30/2021 - 3 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/29/2021 - 3 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/29/2021 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/22/2020 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/3/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/3/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/10/2020 - 4 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/9/2020 - 4 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/8/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/6/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/6/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/1/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR